Regulation of T Helper Cell Type 2 Immune Response by Controlling Beta-2 Adrenergic Receptor in Dendritic Cells of Patients with Allergic Rhinitis
International Archives of Allergy and Immunology · 2023
DOI: 10.1159/000531956 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Archives of Allergy and Immunology, 2023. Verfasst von Ji Woo Yeon und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine, Korea University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Receptors, Adrenergic, beta-2, Rhinitis, Allergic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Allergic diseases are mediated by T helper cell type 2 (Th2) cells, which are differentiated by dendritic cells (DCs). Recently, it was reported that cAMP concentration in DCs is important for inducing allergic responses. However, the regulatory function of cAMP in DCs in Th2 immune responses is unclear. It was hypothesized that the regulation of G protein-coupled receptors (GPCRs) to increase cAMP levels in DCs would reduce Th2 immune responses.
Methods
Human DCs from patients with allergic rhinitis (AR) and from healthy controls were subjected to next-generation sequencing (NGS) to identify potential GPCR. To investigate the functions of GPCR agonists, the in vitro co-culture experiment that THP-1 cells were differentiated into DCs and cultured with human CD4+ T-cells and an AR animal in vivo model were used.
Results
Among the GPCRs, the beta-2 adrenergic receptor (ADRB2) of allergic DCs was significantly increased by NGS analysis. The expression of ADRB2 was also increased in Der p 1-treated DCs, which was reduced by treatment with the ADRB2 agonist salbutamol. Salbutamol treatment induced cAMP production in THP-1 derived DCs. In an in vitro co-culture experiment, salbutamol-treated DCs reduced the secretion of Th2 cytokine. In an in vivo AR animal experiment, salbutamol-administered mice showed reduced allergic behavior and Th2 cytokine expression in the nasal mucosa.
Conclusions
The regulation of ADRB2 with salbutamol alleviated the allergic response in vitro DC-T cell co-culture and in vivo AR animal models, suggesting that ADRB2 is a therapeutic target for AR and that ADRB2 agonists may be a promising medication for AR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine, Korea University, Seoul, Republic of Korea.
- Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine, Korea University, Seoul, Republic of Korea, autru222@gmail.com.
- Neuroscience Research Institute, Korea University, College of Medicine, Seoul, Republic of Korea, autru222@gmail.com.
- Mucosal Immunology Institute, Korea University, College of Medicine, Seoul, Republic of Korea.
Zitieren
APA
Yeon, J. W., Kim, B., Byun, J., Jung, S., Park, J., Han, M., Baek, S. K., & Kim, T. H. (2023). Regulation of T Helper Cell Type 2 Immune Response by Controlling Beta-2 Adrenergic Receptor in Dendritic Cells of Patients with Allergic Rhinitis. International Archives of Allergy and Immunology. https://doi.org/10.1159/000531956
Vancouver
Yeon JW, Kim B, Byun J, Jung S, Park J, Han M, et al. Regulation of T Helper Cell Type 2 Immune Response by Controlling Beta-2 Adrenergic Receptor in Dendritic Cells of Patients with Allergic Rhinitis. International Archives of Allergy and Immunology. 2023. doi:10.1159/000531956
BibTeX
@article{Yeon2023,
author = {Yeon, Ji Woo and Kim, Byoungjae and Byun, Junhyoung and Jung, Semyoung and Park, Jaehyung and Han, Munsoo and Baek, Seung-Kuk and Kim, Tae Hoon},
title = {Regulation of T Helper Cell Type 2 Immune Response by Controlling Beta-2 Adrenergic Receptor in Dendritic Cells of Patients with Allergic Rhinitis},
journal = {International Archives of Allergy and Immunology},
year = {2023},
doi = {10.1159/000531956}
}
EUVIMED